Day 1 - Thursday 15 October, 2026
All times are in China Standard Time (CST, UTC+8)
| 8:40 a.m. |
WELCOME REMARKS |
| 9:00 a.m. |
Keynote Talk The Dance of Proteins and DNA in Nucleotide Excision Repair Wei Yang, National Institutes of Health (NIH), USA |
Session I: Frontiers in Genome Maintenance Mechanisms
| 10:00 a.m. |
Invited Talk Mitsuko Masutani, Nagasaki University, Japan |
| 10:55 a.m. |
Invited Talk Humanizing Yeast Origin Recognition Complex for the Study of Human Diseases Bik Tye, Cornell University, USA |
| 11:20 a.m. |
Invited Talk The genomic outcomes of DNA breakage and chromosome fragmentation Cheng-Zhong Zhang, Dana-Farber Cancer Institute and Harvard Medical School, USA |
| 11:45 a.m. |
Invited Talk René Medema, Princess Máxima Center for Pediatric Oncology, The Netherlands |
Session II: Targeting DNA replication and repair vulnerabilities
| 2:00 p.m. |
Invited Talk Philipp Oberdoerffer, Johns Hopkins School of Medicine, USA |
| 2:25 p.m. |
Invited Talk Ting Liu, Zhejiang University, China |
| 2:50 p.m. |
Invited Talk Nicola Curtin, Newcastle University, UK |
Session III: DDR defects and synthetic lethality
| 4:00 p.m. |
Invited Talk SPOTing molecular switches of cell plasticity Xin Lu, Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, UK |
| 4:25 p.m. |
Invited Talk BRCAness Regulation by OFD1 and Centrosomal Cytoskeleton Dynamics Qing Zhong, Shanghai Jiaotong University School of Medicine, China |
| 4:50 p.m. |
Invited Talk Christopher Lord, The Institute of Cancer Research, UK |
Day 2 - Friday 16 October, 2026
All times are in China Standard Time (CST, UTC+8)
| 9:00 a.m. |
Keynote Talk Zhijian ‘James’ Chen, University of Texas Southwestern Medical Center, USA |
Session IV: DDR-targeted combination therapy
| 10:00 a.m. |
Invited Talk Feng Wang, Sun Yat-sen University Cancer Center, China |
| 10:55 a.m. |
Invited Talk Liang Kang, Sun Yat-sen University, China |
| 11:20 a.m. |
Invited Talk Zhenkun Lou, Mayo Clinic, USA |
Session V: Resistance mechanisms associated with DDR deficiency
| 2:00 p.m. |
Invited Talk Metabolic mediated DNA Repair Contributes to the Chemosensitivity in Cancer Jian Yuan, School of Medicine, Tongji University, China |
| 2:25 p.m. |
Invited Talk PARP inhibitors induce centromeric DNA rearrangements Stephen West, The Francis Crick Institute, UK |
| 2:50 p.m. |
Invited Talk Elaine Sanij, St Vincent’s Institute of Medical Research, Australia |
| 4:15 p.m. |
Meet-the-Editor Session
|
Day 3 - Saturday 17 October, 2026
All times are in China Standard Time (CST, UTC+8)
Session VI: Genomic instability and innate immune signaling
| 9:00 a.m. |
Invited Talk Li Lan, Duke University, USA |
| 9:25 a.m. |
Invited Talk Zhongsheng You, Chinese Institutes for Medical Research, China |
| 9:50 a.m. |
Invited Talk Yaping Huang, Chinese Institutes for Medical Research, China |
| 10:45 a.m. |
Invited Talk Challenges and Opportunities in PARP-Based Cancer Therapy Shan Zha, Columbia University Irving Medical Center, USA |
| 12:10 p.m. |
CLOSING REMARKS |
Preliminary program – subject to change. Last updated: Aug 21, 2026.